Teng CW, He MR, Zhao YQ and Yang H. Effect of highly active antiretroviral therapy on body metabolism and T lymphocyte subpopulation in AIDS patients. J Guizhou Med Uni. 2019;44(06):712-20.

Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders. J Leukoc Biol. 2020;107(4):597-612. doi: 10.1002/JLB.4MR1019-189R. [PubMed: 31965635].

Gaardbo JC, Hartling HJ, Gerstoft J, Nielsen SD. Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions. Clin Dev Immunol. 2012;2012:670957. doi: 10.1155/2012/670957. [PubMed: 22474480].

Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, et al. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr. 2010;55(4):451-9. doi: 10.1097/qai.0b013e3181ec28ff. [PubMed: 21105259].

Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Roge B, et al. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study. BMC Infect Dis. 2010;10:318. doi: 10.1186/1471-2334-10-318. [PubMed: 21044307].

Reekie J, Kosa C, Engsig F, Monforte AD, Wiercinska-Drapalo A, Domingo P, et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer. 2010;116(22):5306-15. doi: 10.1002/cncr.25311. [PubMed: 20661911].

Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011;25(14):1747-51. doi: 10.1097/QAD.0b013e32834a40cd. [PubMed: 21750419].

Kolte L. Thymic function in HIV-infection. Dan Med J. 2013;60(4):B4622. [PubMed: 23651726].

Boyer Z, Palmer S. Targeting immune checkpoint molecules to eliminate latent HIV. Front Immunol. 2018;9:2339. doi: 10.3389/fimmu.2018.02339. [PubMed: 30459753].

Sabbatini F, Bandera A, Ferrario G, Trabattoni D, Marchetti G, Franzetti F, et al. Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients. PLoS One. 2010;

(11):e14119. doi: 10.1371/journal.pone.0014119. [PubMed: 21124762].

Bourinbaiar AS , Batbold U , Efremenko Y , Sanjagdorj M , Botov D , Damdinpurev N, et al. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month. J Clin Tuberc Other Mycobact Dis. 2019;18:100141. doi: 10.1016/j.jctube.2019.100141. [PubMed: 31890902].

He MR, Chen ZF, Yang H, Cao YP, Xie LH, Xie XM. Impact of Mycobacterium vaccae vaccine on CD4 + T cell and CD8+ T cell counts and viral load in asymptomatic HIV-infected patients. Int J Med Lab. 2014;35(06):675-9.

Espert L, Beaumelle B, Vergne I.. Autophagy in Mycobacterium tuberculosis and HIV infections. Front Cell Infect Microbiol. 2015;5:49. doi: 10.3389/fcimb.2015.00049. [PubMed: 26082897].

Yasunaga M. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Semin Cancer Biol. 2020;64:1-12. doi: 10.1016/j.semcancer.2019.06.001. [PubMed: 31181267].

Nguyen TP, Shukla S, Asaad R, Freeman ML, Lederman MM, Harding CV et al. Responsiveness to IL-7 but not to IFN-alpha is diminished in CD4(+) T cells from treated HIV infected patients who experience poor CD4(+) T-cell recovery. AIDS. 2016;30(13):2033-42. doi: 10.1097/QAD.0000000000001161. [PubMed: 27191978].

Mercer F, Khaitan A, Kozhaya L, Aberg JA, Unutmaz D. Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors. J Immunol. 2014;193(3):1047-54. doi: 10.4049/jimmunol. 1302936. [PubMed: 24958901].

Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol. 2013;14(4):307-8. doi: 10.1038/ni.2554. [PubMed: 23507634].

Natalini A, Simonetti S, Favaretto G, Peruzzi G, Antonangeli F, Santoni A, et al. OMIP-079: Cell cycle of CD4+ and CD8+ naïve/memory T cell subsets, and of Treg cells from mouse spleen. Cytometry A. 2021;99(12):1171-5. doi: 10.1002/cyto.a.24509. [PubMed: 34668313].

Appay V, Sauce D. Naive T cells: the crux of cellular immune aging?. Exp Gerontol. 2014;54:90-3. doi: 10.1016/j.exger.2014.01.003. [PubMed: 24440387].

Zhou H, Zhao H, Hao Y, Song C, Han J, Zhang J, et al. Excessive conversion and impaired thymic output contribute to disturbed regulatory T-cell homeostasis in AIDS patients with low CD4 cell counts. AIDS. 2013;27(7):1059-69. doi: 10.1097/QAD.0b013e32835e2b99. [PubMed: 23299175].

Li A, Zhu W, Yin J, Huang X, Sun L, Hua W, et al. A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis. BMC Infect Dis. 2021;21(1):500. doi: 10.1186/s12879-021-06138-z. [PubMed: 34051748].